Literature DB >> 10643908

Sequence diversity of the merozoite surface protein 1 of Plasmodium falciparum in clinical isolates from the Kilombero District, Tanzania.

G Jiang1, C Daubenberger, W Huber, H Matile, M Tanner, G Pluschke.   

Abstract

Merozoite surface protein 1 of Plasmodium falciparum (PfMSP-1) is regarded as a key candidate antigen for malaria vaccine development. It exhibits significant antigenic polymorphism and has been divided into 17 building blocks based on the analysis of sequence diversity. Differences in the antigenic composition of PfMSP-1 in local P. falciparum populations may result in differences in the efficacy of vaccines, which contain sequences of particular allelic variant(s) of PfMSP-1. To contribute to the required knowledge of genetic diversity of malaria parasites in geographically diverse regions, we have used the polymerase chain reaction (PCR) to analyze the sequence diversity of blocks 1-4 of PfMSP-1 in disease isolates from the Kilombero District in Tanzania. In the semi-conserved block 1, in which dimorphic amino acid variances have been described at three positions, we found three of the five previously described combinations of these three pairs of amino acids. In addition one combination was found, which has not been reported before in parasite isolates from different locations worldwide. Of the two sequence variants, which were dominating, one (S44-Q47-V52) corresponded to the 83.1 sequence incorporated into the SPf66 malaria peptide vaccine, while the other one (G44-H47-I52) differed from the previous in all three dimorphic amino acids. The partial protection observed in a phase III SPf66 trial conducted in the Kilombero District in children aged 1-5, thus does not seem to be associated with a clear dominance of favourable variants of block 1 of PfMSP-1 in this area. All three different principle types of block 2, the major polymorphic region of PfMSP-1, were found in the Tanzanian isolates. Most of the sequences contained K1-type tripeptide repeats, but clones with MAD20-type repeats or no repetitive sequence (RO33-type block 2) were also present. K1- and MAD20-type tripeptide repeat motifs were never mixed within one parasite clone. In one sequence a hexapeptide repeat was found at the end of block 2, which has not been reported before. Dimorphism in 13 of the 17 previously described variable positions of the semi-conserved block 3 and three of four recombination types of block 4 (K/K, M/K and M/M) were found among the Tanzanian isolates. Apart from previously described dimorphic amino acid positions, polymorphism was rare in the non-repeated building blocks. Selection and spreading of parasite variants, which contain amino acid exchanges at other than the dimorphic positions thus, is not a common event. Parasite isolates frequently harboured more than one PfMSP-1 allele. Three of the four heterogeneous isolates analysed contained two different general types of sequences. One isolate contained at least four distinct clones, demonstrating the high endemicity of malaria in the Kilombero District, which is a well-established site for malaria vaccine field trials.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10643908     DOI: 10.1016/s0001-706x(99)00045-5

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  11 in total

1.  Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.

Authors:  David R Cavanagh; Daniel Dodoo; Lars Hviid; Jørgen A L Kurtzhals; Thor G Theander; Bartholomew D Akanmori; Spencer Polley; David J Conway; Kojo Koram; Jana S McBride
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

2.  Plasmodium falciparum populations from northeastern Myanmar display high levels of genetic diversity at multiple antigenic loci.

Authors:  Lili Yuan; Hui Zhao; Lanou Wu; Xiaomei Li; Daniel Parker; Shuhui Xu; Yousheng Zhao; Guohua Feng; Ying Wang; Guiyun Yan; Qi Fan; Zhaoqing Yang; Liwang Cui
Journal:  Acta Trop       Date:  2012-09-20       Impact factor: 3.112

3.  Identification and characterization of a conserved, stage-specific gene product of Plasmodium falciparum recognized by parasite growth inhibitory antibodies.

Authors:  Claudia A Daubenberger; Diana Diaz; Marija Curcic; Markus S Mueller; Tobias Spielmann; Ulrich Certa; Joachim Lipp; Gerd Pluschke
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

4.  A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response.

Authors:  Graeme J M Cowan; Alison M Creasey; Kelwalin Dhanasarnsombut; Alan W Thomas; Edmond J Remarque; David R Cavanagh
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

5.  A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila.

Authors:  Graeme J M Cowan; Ulrike Bockau; Janna Eleni-Muus; Ingo Aldag; Kay Samuel; Alison M Creasey; Marcus W W Hartmann; David R Cavanagh
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

6.  Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.

Authors:  Bright Adu; Mariama K Cherif; Samuel Bosomprah; Amidou Diarra; Fareed K N Arthur; Emmanuel K Dickson; Giampietro Corradin; David R Cavanagh; Michael Theisen; Sodiomon B Sirima; Issa Nebie; Daniel Dodoo
Journal:  Malar J       Date:  2016-02-27       Impact factor: 2.979

7.  Genetic diversity and antibody responses against Plasmodium falciparum vaccine candidate genes from Chhattisgarh, Central India: Implication for vaccine development.

Authors:  Priyanka Patel; Praveen K Bharti; Devendra Bansal; Rajive K Raman; Pradyumna K Mohapatra; Rakesh Sehgal; Jagadish Mahanta; Ali A Sultan; Neeru Singh
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

8.  Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Authors:  Nitchakarn Noranate; Franck Prugnolle; Hélène Jouin; Adama Tall; Laurence Marrama; Cheikh Sokhna; Marie-Thérèse Ekala; Micheline Guillotte; Emmanuel Bischoff; Christiane Bouchier; Jintana Patarapotikul; Jun Ohashi; Jean-François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  BMC Microbiol       Date:  2009-10-15       Impact factor: 3.605

9.  Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.

Authors:  David R Cavanagh; Clemens H M Kocken; John H White; Graeme J M Cowan; Kay Samuel; Martin A Dubbeld; Annemarie Voorberg-van der Wel; Alan W Thomas; Jana S McBride; David E Arnot
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

10.  An expanded global inventory of allelic variation in the most extremely polymorphic region of Plasmodium falciparum merozoite surface protein 1 provided by short read sequence data.

Authors:  Harvey Aspeling-Jones; David J Conway
Journal:  Malar J       Date:  2018-10-01       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.